Potential implications of long-acting GLP-1 receptor agonists for critically ill

Crit Care. 2024 May 13;28(1):159. doi: 10.1186/s13054-024-04945-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Critical Illness* / therapy
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists